论文部分内容阅读
乳腺癌患者是口服避孕药(oral contraceptive,OC)和激素替代治疗(postmenopausal hormone,PMH)的禁忌证,但目前由于缺少有效的替代药物,因此其安全性还需要进一步的研究。至少有4项研究发现口服避孕药并不增加对侧乳腺癌的风险。另外2项激素替代治疗的随机试验发现PMH明显增加
Breast cancer patients are contraindications to oral contraceptives (OCs) and postmenopausal hormones (PMHs), but their safety needs further study due to the lack of effective alternative drugs. At least four studies have found that oral contraceptives do not increase the risk of contralateral breast cancer. In addition, two randomized trials of hormone replacement therapy found significant increases in PMH